Search research articles
Contact Us
Filters
Showing results (191-200 of 206) with videos related to
Page
of 21
Sort By:
Plos One
|
November 11, 2016
Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial
Robert A Wise, Janet T Holbrook, Gerard Criner, et al.
European Journal of Internal Medicine
|
August 13, 2025
A person-centred clinical approach to the multimorbid patient with COPD
Bartolome R Celli, Leonardo M Fabbri, Abebaw M Yohannes, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 16, 2018
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials
Fernando J Martinez, Klaus F Rabe, Peter M A Calverley, et al.
Alternatives to Laboratory Animals : ATLA
|
June 4, 2016
Assessment of in vitro COPD models for tobacco regulatory science: Workshop proceedings, conclusions and paths forward for in vitro model use
Holger Behrsing, Hans Raabe, Joseph Manuppello, et al.
BMC Genomics
|
July 20, 2013
Design and validation of a supragenome array for determination of the genomic content of Haemophilus influenzae isolates
Rory A Eutsey, N Luisa Hiller, Joshua P Earl, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 27, 2021
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal
Bartolome R Celli, Leonardo M Fabbri, Shawn D Aaron, et al.
Thorax
|
February 10, 2012
Significance of the microbiome in obstructive lung disease
Meilan K Han, Yvonne J Huang, John J Lipuma, et al.
The Journal of Clinical Investigation
|
May 18, 2011
Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice
Matthias Clauss, Robert Voswinckel, Gangaraju Rajashekhar, et al.
Chest
|
December 6, 2016
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
Fernando J Martinez, Klaus F Rabe, Gary T Ferguson, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 26, 2023
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice
Bartolome R Celli, Leonardo M Fabbri, Shawn D Aaron, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 206) with videos related to
Sort By:
Page
of 21
Plos One
|
November 11, 2016
Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial
Robert A Wise, Janet T Holbrook, Gerard Criner, et al.
European Journal of Internal Medicine
|
August 13, 2025
A person-centred clinical approach to the multimorbid patient with COPD
Bartolome R Celli, Leonardo M Fabbri, Abebaw M Yohannes, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 16, 2018
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials
Fernando J Martinez, Klaus F Rabe, Peter M A Calverley, et al.
Alternatives to Laboratory Animals : ATLA
|
June 4, 2016
Assessment of in vitro COPD models for tobacco regulatory science: Workshop proceedings, conclusions and paths forward for in vitro model use
Holger Behrsing, Hans Raabe, Joseph Manuppello, et al.
BMC Genomics
|
July 20, 2013
Design and validation of a supragenome array for determination of the genomic content of Haemophilus influenzae isolates
Rory A Eutsey, N Luisa Hiller, Joshua P Earl, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 27, 2021
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal
Bartolome R Celli, Leonardo M Fabbri, Shawn D Aaron, et al.
Thorax
|
February 10, 2012
Significance of the microbiome in obstructive lung disease
Meilan K Han, Yvonne J Huang, John J Lipuma, et al.
The Journal of Clinical Investigation
|
May 18, 2011
Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice
Matthias Clauss, Robert Voswinckel, Gangaraju Rajashekhar, et al.
Chest
|
December 6, 2016
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
Fernando J Martinez, Klaus F Rabe, Gary T Ferguson, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 26, 2023
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice
Bartolome R Celli, Leonardo M Fabbri, Shawn D Aaron, et al.
Page
of 21